Cipcure represents a sophisticated pharmaceutical formulation combining 500 mg of ciprofloxacin HCl IP with 600 mg of tinidazole IP in each capsule. This powerful dual-drug approach delivers broad-spectrum antibacterial and antiprotozoal action, effectively targeting complex and resistant infections. Manufactured under stringent quality control protocols, each batch ensures maximum purity at 99.90% and therapeutic reliability while maintaining consistent dosage accuracy. The capsules are engineered for optimal bioavailability and patient compliance, featuring robust construction that preserves integrity throughout storage and handling. Available in both round and oval forms, this medication meets diverse patient preferences while delivering reliable infection treatment.

This medication serves critical roles across multiple healthcare sectors including hospital pharmacies, clinical institutions, and outpatient care facilities. Pharmaceutical distributors and wholesalers rely on Cipcure for its consistent quality and effectiveness in treating diverse infections. Medical procurement programs and healthcare supply businesses value its comprehensive coverage against various pathogens, making it essential inventory for addressing common and complex infection cases. The product's versatility supports healthcare providers in both urban and rural settings, where reliable antibiotic solutions are crucial for patient care and infection management.

The business value of Cipcure lies in its proven reliability and manufacturer commitment to quality assurance. Each batch undergoes rigorous testing to ensure minimal side effects while maintaining high treatment success rates. The extended shelf life supports efficient inventory management for distributors, reducing waste and maximizing return on investment. OEM supply options allow businesses to develop solutions that meet specific market demands, creating competitive advantages in the pharmaceutical supply chain. This combination of clinical efficacy and business practicality makes Cipcure a trusted partner for healthcare providers and pharmaceutical businesses seeking reliable infection treatment solutions.

Key Features:
- Contains 500 mg ciprofloxacin HCl IP and 600 mg tinidazole IP per capsule
- Medicine grade purity at 99.90% ensuring therapeutic effectiveness
- Available in both round and oval capsule forms for patient preference
- Extended shelf life supporting inventory management efficiency
- OEM supply type with complete customization and branding options

Benefits:
- Dual-action formula provides comprehensive coverage against bacterial and protozoal infections
- High purity at 99.90% ensures consistent therapeutic results and patient safety
- Flexible capsule shapes accommodate different patient preferences and administration needs
- Long shelf life reduces inventory waste and supports efficient supply chain management
- OEM options enable tailored solutions for specific market requirements and branding needs